Bilan de 4 ans du Contrat de bon usage : conformité aux référentiels - cas des anti-TNFα

The use of anti-TNFα drugs has progressed over the last 4 years, in accordance with the “contrat de bon usage”. This is due to a better knowledge of these drugs, a good evolution of guidelines and the active participation of the medical team in the “contrat de bon usage” plan.